BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Piché A. Pathobiological role of MUC16 mucin (CA125) in ovarian cancer: Much more than a tumor biomarker. World J Obstet Gynecol 2016; 5(1): 39-49 [DOI: 10.5317/wjog.v5.i1.39]
URL: https://www.wjgnet.com/1948-5182/full/v5/i1/39.htm
Number Citing Articles
1
Alessandra Battaglia, Alexia Buzzonetti, Marco Fossati, Giovanni Scambia, Andrea Fattorossi, Madi R. Madiyalakan, Yolanda D. Mahnke, Christopher Nicodemus. Translational immune correlates of indirect antibody immunization in a randomized phase II study using scheduled combination therapy with carboplatin/paclitaxel plus oregovomab in ovarian cancer patientsCancer Immunology, Immunotherapy 2020; 69(3): 383 doi: 10.1007/s00262-019-02456-z
2
Banu Deveci, Belgin Sert Serdar, Pınar Karabacakoğlu Kemik, Hatice Şimşek Keskin, Nuri Yildirim, Necmettin Özdemir, Tuğba Erkmen, Meral Koyuncuoğlu, Mustafa Coşan Terek, Uğur Saygili, Semra Koçtürk. CA125, YKL-40, HE-4 and Mesothelin: a new serum biomarker combination in discrimination of benign and malign epithelial ovarian tumorTurkish Journal of Biochemistry 2019; 44(4): 438 doi: 10.1515/tjb-2019-0038
3
Isabelle Matte, Perrine Garde-Granger, Paul Bessette, Alain Piché. Ascites from ovarian cancer patients stimulates MUC16 mucin expression and secretion in human peritoneal mesothelial cells through an Akt-dependent pathwayBMC Cancer 2019; 19(1) doi: 10.1186/s12885-019-5611-7
4
Kathryn M. Muilenburg, Carly C. Isder, Prakash Radhakrishnan, Surinder K. Batra, Quan P. Ly, Mark A. Carlson, Michael Bouvet, Michael A. Hollingsworth, Aaron M. Mohs. Mucins as contrast agent targets for fluorescence-guided surgery of pancreatic cancerCancer Letters 2023; 561: 216150 doi: 10.1016/j.canlet.2023.216150